A lack of quality clinical data is hindering machine learning models for oncology and other treatments, says Steve Irvine, CEO of integrate.ai, who describes how federated learning approaches can enable secure access to a wider array of datasets.
Subscribe to:
Post Comments (Atom)
< + > When Your Billing Team is Overseas: What Data Residency Laws Teach About EHR Access
The following is a guest article by Mohammad Alsaadany, Regional Director at BioNixus It usually surfaces on a Tuesday. A revenue-cycle di...
No comments:
Post a Comment